» Articles » PMID: 36302624

Thermotherapy As an Alternative to Exercise for Metabolic Health in Obese Postmenopausal Women: Focus on Circulating Irisin Level

Overview
Specialty Pharmacology
Date 2022 Oct 27
PMID 36302624
Authors
Affiliations
Soon will be listed here.
Abstract

Irisin is a myokine caused by exercise that improves insulin resistance and weight loss. However, under unfavorable conditions such as air pollution, and during the pandemic, outdoor activities are uncomfortable. Therefore, in this study, the effect of heat therapy (half bath 42 ± 0.5°C for 30 min) on irisin circulation levels as an exercise alternative for middle-aged obese women after menopause was investigated. Subjects were 33 women aged 49.54 ± 6.04 years, with parameters of height, 160.12 ± 4.33 cm, weight, 69.71 ± 7.52 kg, body surface area 1.73 ± 0.13 m, body mass index, 27.19 ± 3.40 kg/m. The results suggest that circulating irisin levels showed a significant increase after one-time thermotherapy (TH-1). However, the increase in circulating irisin levels after 15 treatments (TH-15, 5 days/week, 3 weeks) was significantly varied. The level of adiponectin, which increases fatty oxidation to reduce fatty deposition, increased significantly at TH-1, but further increased at TH-15, which was significantly different from the level of TH-1. In addition, the basic serum free fatty acid (FFA) level was significantly increased at TH-15 compared to TH-1. Significant differences were also found in the lipid profile (body mass index, waist circumference, and % body fat). Thermotherapy can significantly increase the tympanic temperature and induce changes in circulating irisin and adiponectin levels. Thus, it resulted in positive changes in FFA and lipid profiles. Therefore, repeated thermotherapy is effective in increasing circulating irisin levels in postmenopausal obese women.

Citing Articles

Precision proteomics with TurboID: mapping the suborganelle landscape.

Kim H, Kim K Korean J Physiol Pharmacol. 2024; 28(6):495-501.

PMID: 39467713 PMC: 11519719. DOI: 10.4196/kjpp.2024.28.6.495.


The therapeutic potential of irisin to mitigate the risk of metabolic syndrome in postmenopausal women.

Parkin R, Murray A Front Reprod Health. 2024; 6:1355922.

PMID: 39040132 PMC: 11260725. DOI: 10.3389/frph.2024.1355922.


Barefoot walking improves cognitive ability in adolescents.

Kim T, Seo D, Bae J, Han J Korean J Physiol Pharmacol. 2024; 28(4):295-302.

PMID: 38926837 PMC: 11211751. DOI: 10.4196/kjpp.2024.28.4.295.

References
1.
Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

2.
Amiri P, Deihim T, Nakhoda K, Hasheminia M, Montazeri A, Azizi F . Metabolic syndrome and health-related quality of life in reproductive age and post-menopausal women: Tehran Lipid and Glucose Study. Arch Iran Med. 2014; 17(6):423-8. DOI: 014176/AIM.009. View

3.
Wenger C . Heat of evaporation of sweat: thermodynamic considerations. J Appl Physiol. 1972; 32(4):456-9. DOI: 10.1152/jappl.1972.32.4.456. View

4.
Nappi R, Palacios S . Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014; 17(1):3-9. DOI: 10.3109/13697137.2013.871696. View

5.
Sugenoya J, Ogawa T . Characteristics of central sudomotor mechanism estimated by frequency of sweat expulsions. Jpn J Physiol. 1985; 35(5):783-94. DOI: 10.2170/jjphysiol.35.783. View